PIK3CA and Ehlers-Danlos syndrome, musculocontractural type: Furthermore, our analyses of this pathway genes revealed that the presence of PIK3CA mutation significantly predicts a poor overall survival (p = 0.0289) in patients with aggressive phenotypes suggesting a vital role of PIK3CA mutation in PDTCs and ATCs (Figure 5G).